Back

Permissive cardiotoxicity – how low can you go?

19 June 2026 (09:30 - 09:45)
Organised by: Logo
Congress Presentation Part of: Tackling challenging problems with expert answers Management of Cardiovascular Disease in Patients with Cancer Open Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Doctor Wouter Meijers

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Should we rechallenge immune checkpoint inhibitors after myocarditis?
Professor J. Salem (Paris, FR)
Slides
Presentation thumbnail
Fluoropyrimidine-induced cardiovascular toxicity – what is new?
Professor C. Manisty (London, GB)
Slides
Presentation thumbnail
Clinical case management: tackling challenging problems with expert answers - discussion

Access the full session

Session thumbnail
Tackling challenging problems with expert answers
Video

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 09:30 CET
You may be interested in
thumbnail
Congress Presentation
The delicate balance of permissive cardiotoxicity strategy in cancer-related cardiac dysfunction at a tertiary Centre: a comparative analysis
20 June 2025
thumbnail
Congress Session
Cardio-oncology: when therapy leads to failure
17 May 2025
thumbnail
Congress Session
Young Investigator Award (YIA) Basic Science
17 May 2025
thumbnail
Congress Session
New insights into cancer therapy-related cardiac dysfunction
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources